Genmab falls 4.8% after cancer drug trial fails to meet goal

lunes, 19 de enero de 2026, 3:04 am ET1 min de lectura
GMAB--

Genmab falls 4.8% after cancer drug trial fails to meet goal

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios